Julien Villaudy

Years Active: 2019-2021
Publications (10 Years): 3

AIMM therapeutics

École normale supérieure de Lyon (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AIMM therapeutics Jan 01 2013

Netherlands

scientist

Education History

École normale supérieure de Lyon Sep 01 2008 - Dec 22 2011

France

PHD :: Virology

École normale supérieure de Lyon Sep 01 2006 - Jun 30 2008

France

MSC :: Biologie

Publications

Mitch Brinkkemper, Philip J M Brouwer, Pauline Maisonnasse, Marloes Grobben, Tom G Caniels, Meliawati Poniman, Judith A Burger, Ilja Bontjer, Melissa Oomen, Joey H Bouhuijs, Cynthia A van der Linden, Julien Villaudy, Yme U van der Velden, Kwinten Sliepen, Marit J VAN Gils, Roger Le Grand, Rogier W Sanders
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern. NPJ vaccines 6 (1) (2021)
Otávio de Melo Espíndola, Esther Siteur-van Rijnstra, Esmay Frankin, Kees Weijer, Yme Ubeles van der Velden, Ben Berkhout, Bianca Blom, Julien Villaudy
Early Effects of HTLV-1 Infection on the Activation, Exhaustion, and Differentiation of T-Cells in Humanized NSG Mice. Cells 10 (10) (2021)
Lina Bartels, Greta de Jong, Marijn A Gillissen, Etsuko Yasuda, Veronika Kattler, Camille Bru, Christien Fatmawati, Susan E van Hal-van Veen, Madalina G Cercel, Gemma Moiset, Arjen Q Bakker, Pauline M van Helden, Julien Villaudy, Mette D Hazenberg, Hergen Spits, Koen Wagner
A Chemo-enzymatically Linked Bispecific Antibody Retargets T Cells to a Sialylated Epitope on CD43 in Acute Myeloid Leukemia. Cancer research 79 (13) (2019)

Julien Villaudy.css-eqlu8i{font-size:small;padding-left:4px;}